Search for other papers by Shi-en Fu in
Google Scholar
PubMed
Search for other papers by Rou-mei Wang in
Google Scholar
PubMed
Search for other papers by Xing-huan Liang in
Google Scholar
PubMed
Search for other papers by Jing Xian in
Google Scholar
PubMed
Search for other papers by Jie Pan in
Google Scholar
PubMed
Search for other papers by Xue-lan Chen in
Google Scholar
PubMed
Search for other papers by Cheng-cheng Qiu in
Google Scholar
PubMed
Search for other papers by Zhi-ping Tang in
Google Scholar
PubMed
Search for other papers by Ying-fen Qin in
Google Scholar
PubMed
Search for other papers by Hai-yan Yang in
Google Scholar
PubMed
Department of Endocrinology, The Affiliated Hospital of Guilin Medical University, Guilin, China
Search for other papers by Li-li Huang in
Google Scholar
PubMed
Search for other papers by Ya-qi Kuang in
Google Scholar
PubMed
Search for other papers by Yan Ma in
Google Scholar
PubMed
Search for other papers by Zuo-jie Luo in
Google Scholar
PubMed
min at 956 g . Serum thyroid hormone concentrations were assessed using the chemiluminescent immunoassay (TEGEN, TESMI i-200, Shanghai, China). For this assay, the limit of detection for free triiodothyronine (FT3) was 3.6–6.0 pmol/L, free
Search for other papers by Kusum Lata in
Google Scholar
PubMed
Search for other papers by Pinaki Dutta in
Google Scholar
PubMed
Search for other papers by Subbiah Sridhar in
Google Scholar
PubMed
Search for other papers by Minakshi Rohilla in
Google Scholar
PubMed
Search for other papers by Anand Srinivasan in
Google Scholar
PubMed
Search for other papers by G R V Prashad in
Google Scholar
PubMed
Search for other papers by Viral N Shah in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
vacutainers at the initial visit. Each blood sample was analysed for TSH, free tri-iodothyronine (FT 3 ), free T 4 (FT 4 ) and anti-TPO by electro-chemiluminescence immunoassay (ELECSYS-2010, Roche–Hitachi Diagnostics). The reference range for the above
Search for other papers by M Langeveld in
Google Scholar
PubMed
Search for other papers by C Y Tan in
Google Scholar
PubMed
Search for other papers by M R Soeters in
Google Scholar
PubMed
Search for other papers by S Virtue in
Google Scholar
PubMed
Search for other papers by G K Ambler in
Google Scholar
PubMed
NIHR/Wellcome Trust Clinical Research Facility, Addenbrookes Hospital, Cambridge, UK
Search for other papers by L P E Watson in
Google Scholar
PubMed
NIHR/Wellcome Trust Clinical Research Facility, Addenbrookes Hospital, Cambridge, UK
Search for other papers by P R Murgatroyd in
Google Scholar
PubMed
Search for other papers by V K Chatterjee in
Google Scholar
PubMed
Search for other papers by A Vidal-Puig in
Google Scholar
PubMed
ANOVA for the effect of temperature P < 0.001). Figure 4 (A) Plasma glucose, (B) non-esterified free fatty acid (NEFA), (C) cortisol, (D) thyroid-stimulating hormone (TSH), (4) free thyroxine (FT4) (E) and free tri-iodothyronine (FT3) (F) over
Search for other papers by Yue-Yue Wang in
Google Scholar
PubMed
Search for other papers by Qian Wu in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
Search for other papers by Xiao-Quan Xu in
Google Scholar
PubMed
Search for other papers by Fei-Yun Wu in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Huan-Huan Chen in
Google Scholar
PubMed
.37–40.00) 9.22 ± 10.20 (0.10–40.00) 0.695 Diplopia presence 12/11 11/3 0.166 a Statistical significance is indicated by P values < 0.05. CAS, clinical activity score; F, female; FT3, free triiodothyronine; FT4, free thyroxine
Search for other papers by Lingjuan Li in
Google Scholar
PubMed
Search for other papers by Jing Qin in
Google Scholar
PubMed
Search for other papers by Lin Ren in
Google Scholar
PubMed
Search for other papers by Shiyuan Xiang in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Medical Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
Search for other papers by Xiaoyun Cao in
Google Scholar
PubMed
Search for other papers by Xianglan Zheng in
Google Scholar
PubMed
Search for other papers by Zhiwen Yin in
Google Scholar
PubMed
National Center for Neurological Disorders, Shanghai, China
Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China
Neurosurgical Institute of Fudan University, Shanghai, China
Shanghai Key Laboratory of Medical Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
Search for other papers by Nidan Qiao in
Google Scholar
PubMed
.1) 0.250 Cortisol (μg/dL) 5.3 (3.2, 10.3) 4.7 (2.5, 7.4) 0.142 Free triiodothyronine (pmol/L) 2.9 (0.7) 2.9 (0.8) 0.970 Free thyroxine (pmol/L) 15.5 (4.6) 15.2 (4.7) 0.716 Outcomes Postoperative
Search for other papers by M von Wolff in
Google Scholar
PubMed
Laboratory of Biometry, University of Thessaly, Volos, Greece
Search for other papers by C T Nakas in
Google Scholar
PubMed
Division of Pneumology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Search for other papers by M Tobler in
Google Scholar
PubMed
Search for other papers by T M Merz in
Google Scholar
PubMed
Search for other papers by M P Hilty in
Google Scholar
PubMed
Search for other papers by J D Veldhuis in
Google Scholar
PubMed
Search for other papers by A R Huber in
Google Scholar
PubMed
Search for other papers by J Pichler Hefti in
Google Scholar
PubMed
−80°C thereafter. Cortisol, prolactin, thyroid-stimulating hormone (TSH), free tetraiodothyronine (fT4), free triiodothyronine (fT3), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone (testosterone) were analysed
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Search for other papers by Mira Jakovcevski in
Google Scholar
PubMed
. Evaluation of pituitary function was based on basal measurements of thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and total testosterone (in men) or estradiol
Search for other papers by Elin Kahlert in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Martina Blaschke in
Google Scholar
PubMed
Search for other papers by Knut Brockmann in
Google Scholar
PubMed
Search for other papers by Clemens Freiberg in
Google Scholar
PubMed
Search for other papers by Onno E Janssen in
Google Scholar
PubMed
Search for other papers by Nikolaus Stahnke in
Google Scholar
PubMed
Search for other papers by Domenika Strik in
Google Scholar
PubMed
Search for other papers by Martin Merkel in
Google Scholar
PubMed
Search for other papers by Alexander Mann in
Google Scholar
PubMed
Search for other papers by Klaus-Peter Liesenkötter in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Heide Siggelkow in
Google Scholar
PubMed
result of a change of residence. Thyroid function was evaluated by measuring thyroid-stimulating hormone (TSH) (mU/L), free thyroid hormone (fT4, pg/mL) and free triiodothyronine (fT3, pg/mL). The antibodies (AB) TPO-AB/MAK-AB (thyroperoxidase
Department of Immunology, Nanjing Medical University, Jiangsu, China
Search for other papers by Yun Hu in
Google Scholar
PubMed
Search for other papers by Na Li in
Google Scholar
PubMed
Search for other papers by Peng Jiang in
Google Scholar
PubMed
Search for other papers by Liang Cheng in
Google Scholar
PubMed
Search for other papers by Bo Ding in
Google Scholar
PubMed
Search for other papers by Xiao-Mei Liu in
Google Scholar
PubMed
Search for other papers by Ke He in
Google Scholar
PubMed
Search for other papers by Yun-Qing Zhu in
Google Scholar
PubMed
Search for other papers by Bing-li Liu in
Google Scholar
PubMed
Search for other papers by Xin Cao in
Google Scholar
PubMed
Search for other papers by Hong Zhou in
Google Scholar
PubMed
Search for other papers by Xiao-Ming Mao in
Google Scholar
PubMed
.928 – Thyroid volume (mL) 11.00 ± 1.2 38.59 ± 23.45 0.274 Females <18 mL Male <25 mL FT3, free triiodothyronine; FT4, free thyroxin; n , number; Tg, thyroglobulin; Tg-Ab, thyroglobulin antibody; TPO-Ab, thyroid peroxidase antibody; TR
Search for other papers by Nese Cinar in
Google Scholar
PubMed
Search for other papers by Alper Gurlek in
Google Scholar
PubMed
subclinical hypothyroid patients No significant difference in ADP levels between the groups 53 controls ↑ ADP after normalization of thyroid status ↑, Increase; ↓, decrease; ↔, no change; ADP, adiponectin; fT 4 , free thyroxine; fT 3 , free triiodothyronine